Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Feb 06, 2020 6:15pm
204 Views
Post# 30654581

RE:RE:RE:RE:RE:62-66 million in rev if true ouch

RE:RE:RE:RE:RE:62-66 million in rev if true ouchSadly for all of the shareholders here, it's never a good sign when a company reports falling revenues for 2 sequential quarters in a row.  Especially when it is done in conjunction with rising selling/marketing and general admin expenses when the company is facing a cash crunch situation.

Looks like the coming Q3 reporting quarter will also not be any better, even with Cannabis 2.0 now in play and exports to the piddly German medical market back on line.  SAD, SAD, SAD!!!

I certainly hope they do not make the same red face mistake as last quarter and end up missing on their revised lowered financials for this reporting quarter.

Stoktrd wrote:

You read the news release? What a joke, you just made that up. I read you are cought with your shorts down low and need to close your positions. Acb will post better than expected financials.  They brought 2 new board members in, look who they are. They had to replace Booth and glad it happened now.



 

Skater wrote: Read news release.  It will explode, for sure.  Maybe as soon as tomorrow..  lol

 

 



Bullboard Posts